Exact Mass: 281.1277

Exact Mass Matches: 281.1277

Found 500 metabolites which its exact mass value is equals to given mass value 281.1277, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cycloheximide

2,6-PIPERIDINEDIONE, 4-(2-(3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-, (1S-(1.ALPHA.(S*),3.ALPHA.,5.BETA.))-

C15H23NO4 (281.1627)


Cycloheximide appears as colorless crystals. Used as a fungicide and as a anticancer drug. (EPA, 1998) Cycloheximide is a dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. It has a role as a bacterial metabolite, a protein synthesis inhibitor, a neuroprotective agent, an anticoronaviral agent and a ferroptosis inhibitor. It is a member of piperidones, a piperidine antibiotic, an antibiotic fungicide, a dicarboximide, a secondary alcohol and a cyclic ketone. It is functionally related to a piperidine-2,6-dione. Cycloheximide is a natural product found in Streptomyces, Streptomyces griseus, and Streptomyces pulveraceus with data available. Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Origin: Microbe; SubCategory_DNP: Alkaloids derived from lysine, Piperidine alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.773 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.776 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.777 [Raw Data] CBA53_Cycloheximid_pos_50eV.txt [Raw Data] CBA53_Cycloheximid_pos_20eV.txt [Raw Data] CBA53_Cycloheximid_pos_10eV.txt [Raw Data] CBA53_Cycloheximid_pos_40eV.txt [Raw Data] CBA53_Cycloheximid_pos_30eV.txt

   

Pendimethalin

N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzenamine

C13H19N3O4 (281.1375)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3116 CONFIDENCE standard compound; INTERNAL_ID 2549 CONFIDENCE standard compound; INTERNAL_ID 4059 CONFIDENCE standard compound; INTERNAL_ID 8435 D010575 - Pesticides > D006540 - Herbicides KEIO_ID P183; [MS2] KO009157 KEIO_ID P183; [MS3] KO009158 D016573 - Agrochemicals KEIO_ID P183

   

1-Methyladenosine

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


1-Methyladenosine, also known as M1A, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Precise m6A mapping by m6A-CLIP/IP (briefly m6A-CLIP) revealed that a majority of m6A locates in the last exon of mRNAs in multiple tissues/cultured cells of mouse and human, and the m6A enrichment around stop codons is a coincidence that many stop codons locate round the start of last exons where m6A is truly enriched. The methylation of adenosine is directed by a large m6A methyltransferase complex containing METTL3 as the SAM-binding sub-unit. Insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1-3) are reported as a novel class of m6A readers. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

NSC100044

O(6)-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


O6-Methyldeoxy guanosine; DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

Anolobine

1,2-methylenedioxy-9-hydroxynoraporphine

C17H15NO3 (281.1052)


   

Harzianopyridone

Harzianopyridone

C14H19NO5 (281.1263)


   

Balsoxine

2-Phenyl-5-(3,4-dimethoxyphenyl)oxazole

C17H15NO3 (281.1052)


   

Xanomeline tartrate

5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine

C14H23N3OS (281.1562)


Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

Oxoassoanine

Dihydropratosine

C17H15NO3 (281.1052)


   

Triphenylcyanoethylene

2,3,3-Triphenylacrylonitrile; Triphenylcyanoethylene

C21H15N (281.1204)


   

Michelalbine

MEGxp0_001997

C17H15NO3 (281.1052)


   

Diminazene

4-[(2E)-3-(4-carbamimidoylphenyl)triaz-2-en-1-yl]benzene-1-carboximidamide

C14H15N7 (281.1389)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

XANOMELINE

XANOMELINE

C14H23N3OS (281.1562)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

phentolamine

phentolamine

C17H19N3O (281.1528)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

Floribundine

16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


Floribundine is an isoquinoline alkaloid. Floribundine is a natural product found in Annona purpurea, Tephroseris palustris, and other organisms with data available. Alkaloid from Nelumbo nucifera (East India lotus). Floribundine is found in tea, cherimoya, and coffee and coffee products. Floribundine is found in cherimoya. Floribundine is an alkaloid from Nelumbo nucifera (East India lotus

   

2'-O-Methyladenosine

5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


2-O-Methyladenosine is a methylated adenine residue. 2-O-Methyladenosine is a naturally occurring 2-O-methylpurine nucleoside with long lasting hypotensive properties; resistance of 2-O-methyladenosine against adenosine deaminase is thought to contribute to prolonged activity. 2-O-Methyladenosine occurs in human fluids, and they increase in urines of untreated adenosine deaminase (ADA) deficient patients (OMIM 608958). (PMID: 9539952, 6980397) [HMDB] 2-O-Methyladenosine is a methylated adenine residue. 2-O-Methyladenosine is a naturally occurring 2-O-methylpurine nucleoside with long lasting hypotensive properties; resistance of 2-O-methyladenosine against adenosine deaminase is thought to contribute to prolonged activity. 2-O-Methyladenosine occurs in human fluids, and they increase in urines of untreated adenosine deaminase (ADA) deficient patients (OMIM 608958). (PMID: 9539952, 6980397). 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2]. 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2].

   

Phentolamine

3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol

C17H19N3O (281.1528)


Phentolamine is only found in individuals that have used or taken this drug. It is a nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease (PubChem). Phentolamine produces its therapeutic actions by competitively blocking alpha-adrenergic receptors (primarily excitatory responses of smooth muscle and exocrine glands), leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. The action of phentolamine on the alpha adrenergic receptors is relatively transient and the blocking effect is incomplete. The drug is more effective in antagonizing responses to circulating epinephrine and/or norepinephrine than in antagonizing responses to mediator released at the adrenergic nerve ending. Phentolamine also stimulates β-adrenergic receptors and produces a positive inotropic and chronotropic effect on the heart and increases cardiac output. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

8-hydroxymirtazapine

5-methyl-2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(19),8,10,12,15,17-hexaen-17-ol

C17H19N3O (281.1528)


8-hydroxymirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

N6-Methyladenosine

(2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3,4-diol

C11H15N5O4 (281.1124)


N6-Methyladenosine is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820) [HMDB] N6-Methyladenosine is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820). N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

Juzirine

1-((4-Hydroxyphenyl)methyl)-6-methoxy-7-isoquinolinol

C17H15NO3 (281.1052)


Juzirine is found in fruits. Juzirine is an alkaloid from the leaves of Zizyphus jujuba (Chinese date). Alkaloid from the leaves of Zizyphus jujuba (Chinese date). Juzirine is found in fruits.

   

3'-O-Methyladenosine

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


3-O-Methyladenosine is a methylated adenine residue. [HMDB] 3-O-Methyladenosine is a methylated adenine residue. (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol (Adenosine, 3'-O-methyl- (8CI)(9CI)) is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

N-(1-Deoxy-1-fructosyl)threonine

(2S)-3-hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)butanoic acid

C10H19NO8 (281.1111)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)threonine is classified as a Natural Food Constituent (code WA) in the DFC.

   

N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine

4-({[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}amino)benzoate

C12H15N3O5 (281.1012)


N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine is found in mushrooms. N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine is isolated from Agaricus bisporus (button mushroom). Isolated from Agaricus bisporus (button mushroom). N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine is found in mushrooms.

   

(E)-2-Hydroxy-N-desmethyldoxepin

(2E)-2-[3-(methylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-ol

C18H19NO2 (281.1416)


(E)-2-Hydroxy-N-desmethyldoxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)

   

mirtazapine-N-oxide

5-methyl-2,5λ⁵,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaen-5-one

C17H19N3O (281.1528)


mirtazapine-N-oxide is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

1-Methyladenosin

2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

11-Maleimidoundecanoic acid

11-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)undecanoic acid

C15H23NO4 (281.1627)


   

(S)-3-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine

(S)-3-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine hydrochloride

C15H23NO2S (281.1449)


   

4-(4-Fluoronaphthalen-1-yl)-6-isopropylpyrimidin-2-amine

4-(4-fluoronaphthalen-1-yl)-6-(propan-2-yl)pyrimidin-2-amine

C17H16FN3 (281.1328)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

7-phenyl-7-(pyridin-4-yl)hept-6-enoic acid

C18H19NO2 (281.1416)


   

Caffeine, 8-((3-methoxypropyl)amino)-

8-[(3-methoxypropyl)amino]-1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C12H19N5O3 (281.1488)


   

Acetoxyacetylaminofluorene

Acetic acid, ester with N-(fluoren-2-yl)acetohydroxamic acid

C17H15NO3 (281.1052)


D009676 - Noxae > D000477 - Alkylating Agents

   

Apocodeine

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaen-3-ol

C18H19NO2 (281.1416)


   

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)propanoic acid

C15H23NO4 (281.1627)


   

Cycloheximide

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

indoprofen

2-[4-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)phenyl]propanoic acid

C17H15NO3 (281.1052)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

Isbogrel

7-phenyl-7-(pyridin-3-yl)hept-6-enoic acid

C18H19NO2 (281.1416)


   

Isoapocodeine

3-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaen-4-ol

C18H19NO2 (281.1416)


   

Lufironil

N2,N4-bis(2-methoxyethyl)pyridine-2,4-dicarboxamide

C13H19N3O4 (281.1375)


C471 - Enzyme Inhibitor

   

N-Nitrosocimetidine

N-cyano-N-methyl-N-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)-N-nitrosoguanidine

C10H15N7OS (281.1059)


   

N-Nornuciferine

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

L-3-(3-Hydroxy-4-pivaloyloxyphenyl)alanine

2-amino-3-{4-[(2,2-dimethylpropanoyl)oxy]-3-hydroxyphenyl}propanoic acid

C14H19NO5 (281.1263)


   

Northiaden

methyl(3-{9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine

C18H19NS (281.1238)


   

O(6)-Methyl-2'-deoxyguanosine

5-(2-amino-6-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C11H15N5O4 (281.1124)


   

Piberaline

1-benzyl-4-(pyridine-2-carbonyl)piperazine

C17H19N3O (281.1528)


   

Pridopidine

4-(3-Methanesulphonylphenyl)-1-propylpiperidine

C15H23NO2S (281.1449)


C78272 - Agent Affecting Nervous System Pridopidine, a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist. Pridopidine exerts high affinity towards sigma 1 receptor (S1R) with Ki between 70 and 80 nM, which is ~100× higher than its affinity toward D2R.

   

N-(2-(Mercaptomethyl)-3-phenylbutanoyl)-L-alanine

2-{[1-hydroxy-3-phenyl-2-(sulphanylmethyl)butylidene]amino}propanoic acid

C14H19NO3S (281.1086)


   

Sanfetrinem

1-(1-hydroxyethyl)-5-methoxy-2-oxo-1H,2H,5H,6H,7H,8H,8aH,8bH-azeto[2,1-a]isoindole-4-carboxylic acid

C14H19NO5 (281.1263)


   

4-Methyl-3-[4-(4-oxopyridin-1-yl)phenyl]-4,5-dihydro-1H-pyridazin-6-one

5-methyl-6-[4-(4-oxo-1,4-dihydropyridin-1-yl)phenyl]-2,3,4,5-tetrahydropyridazin-3-one

C16H15N3O2 (281.1164)


   

(-)-Norushinsunine

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14(19),15,17-hexaen-13-ol

C17H15NO3 (281.1052)


(-)-norushinsunine is a member of the class of compounds known as hydroxy-7-aporphines. Hydroxy-7-aporphines are aporphines containing a hydroxyl group at the 7-position (-)-norushinsunine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-norushinsunine can be found in cherimoya, custard apple, and sugar apple, which makes (-)-norushinsunine a potential biomarker for the consumption of these food products.

   

dihydroxyphaseic acid

5-{3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl}-3-methylpenta-2,4-dienoic acid

C15H21O5 (281.1389)


Dihydroxyphaseic acid is also known as dihydroxyphaseate. Dihydroxyphaseic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Dihydroxyphaseic acid can be found in a number of food items such as olive, turmeric, macadamia nut, and shiitake, which makes dihydroxyphaseic acid a potential biomarker for the consumption of these food products.

   

1-Methyladenosine

1-Methyladenosine

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

Cissaglaberrimine

Cissaglaberrimine

C17H15NO3 (281.1052)


   
   

Galanthindole

Galanthindole

C17H15NO3 (281.1052)


   
   

Euchrestine A

Euchrestine A

C18H19NO2 (281.1416)


   
   

Isodutadrupine

Isodutadrupine

C17H15NO3 (281.1052)


   

Mortivinacin C

Mortivinacin C

C14H19NO5 (281.1263)


   

2-Methoxyaporphin-1-ol

2-Methoxyaporphin-1-ol

C18H19NO2 (281.1416)


   

Nornuciferine

Nornuciferine

C18H19NO2 (281.1416)


   

MCULE-5769297339

MCULE-5769297339

C15H23NO4 (281.1627)


   
   

Haplacutine D

Haplacutine D

C18H19NO2 (281.1416)


   

indoprofen

indoprofen

C17H15NO3 (281.1052)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   
   

3-(2-ethyl-5-methylpyrazol-3-yl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(2-ethyl-5-methylpyrazol-3-yl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C12H19N5OS (281.131)


   

N-[(2,2-dimethylpropanoyl)oxy]-6-(ethylthio)pyridine-3-carboximidamide

N-[(2,2-dimethylpropanoyl)oxy]-6-(ethylthio)pyridine-3-carboximidamide

C13H19N3O2S (281.1198)


   

Diethyl 2-[(4-fluoroanilino)methylene]malonate

Diethyl 2-[(4-fluoroanilino)methylene]malonate

C14H16FNO4 (281.1063)


   

Maybridge1_002040

Maybridge1_002040

C14H19NO3S (281.1086)


   

SCHEMBL154292

SCHEMBL154292

C18H19NO2 (281.1416)


   

2-Methyladenosine

2-Methyladenosine

C11H15N5O4 (281.1124)


   

Coumarin 106

Coumarin 106

C18H19NO2 (281.1416)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.416 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.417

   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   
   

7-Alcohol-Spirostaphylotrichin F|spirostaphylotrichin L

7-Alcohol-Spirostaphylotrichin F|spirostaphylotrichin L

C14H19NO5 (281.1263)


   

Me ester-4-Hydroxy-2-[4-(2-pyridinyl)-1,3-butadienyl]benzoic acid

Me ester-4-Hydroxy-2-[4-(2-pyridinyl)-1,3-butadienyl]benzoic acid

C17H15NO3 (281.1052)


   

6beta-Acetoxy-3alpha-tigloyloxytropane

6beta-Acetoxy-3alpha-tigloyloxytropane

C15H23NO4 (281.1627)


   

SCHEMBL14543629

SCHEMBL14543629

C17H15NO3 (281.1052)


   

Me glycoside,4,6-O-benzylidene-alpha-D-Pyranose-3-Amino-3-deoxyglucose

Me glycoside,4,6-O-benzylidene-alpha-D-Pyranose-3-Amino-3-deoxyglucose

C14H19NO5 (281.1263)


   
   

4-Hydroxyanonaine|rel-(4R,6aR)-4-hydroxyanonaine

4-Hydroxyanonaine|rel-(4R,6aR)-4-hydroxyanonaine

C17H15NO3 (281.1052)


   

(+-)-norpukateine|(+-)-obovanine|6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-12-ol|Obovanine

(+-)-norpukateine|(+-)-obovanine|6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-12-ol|Obovanine

C17H15NO3 (281.1052)


   

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin|Euglenapterin

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin|Euglenapterin

C11H15N5O4 (281.1124)


   

Methyl b-neuraminic acid

Methyl b-neuraminic acid

C10H19NO8 (281.1111)


   

5,6-dihydroconstrictosine

5,6-dihydroconstrictosine

C17H15NO3 (281.1052)


   
   
   

Spirostaphylotrichin T

Spirostaphylotrichin T

C14H19NO5 (281.1263)


   

CHEMBL1192721

CHEMBL1192721

C15H23NO4 (281.1627)


   

SCHEMBL15338502

SCHEMBL15338502

C11H15N5O4 (281.1124)


   

Scholarisine II

Scholarisine II

C17H15NO3 (281.1052)


   

AKOS017074913

AKOS017074913

C18H19NO2 (281.1416)


   

SCHEMBL9735646

SCHEMBL9735646

C18H19NO2 (281.1416)


   

aristolactam BII|cepharanone B

aristolactam BII|cepharanone B

C17H15NO3 (281.1052)


   

piperolactam B

piperolactam B

C17H15NO3 (281.1052)


   

(Z)-4-methoxy-7-[(3-methylbuta-1,3-dienyloxy)]furo[2,3-b]quinoline|leptanoine A

(Z)-4-methoxy-7-[(3-methylbuta-1,3-dienyloxy)]furo[2,3-b]quinoline|leptanoine A

C17H15NO3 (281.1052)


   

(-)-ASIMILOBINE

(-)-ASIMILOBINE

C17H15NO3 (281.1052)


   

(S)-benzhydryl 3,3-dimethylaziridine-2-carboxylate|benzhydryl (S)-3,3-dimethylaziridine-2-carboxylate

(S)-benzhydryl 3,3-dimethylaziridine-2-carboxylate|benzhydryl (S)-3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

(+)-Dicrotaline

(+)-Dicrotaline

C14H19NO5 (281.1263)


   

norushinsunine

norushinsunine

C17H15NO3 (281.1052)


   

(+)-Isoboldine

(+)-Isoboldine

C18H19NO2 (281.1416)


   

Curcutriolamide

Curcutriolamide

C15H23NO4 (281.1627)


   

5,6,6a,7-Tetrahydro-6-methyl-10-methoxy-4H-dibenzo[de,g]quinolin-9-ol

5,6,6a,7-Tetrahydro-6-methyl-10-methoxy-4H-dibenzo[de,g]quinolin-9-ol

C18H19NO2 (281.1416)


   

1-(dibenzylamino) cyclopropanecarboxylic acid

1-(dibenzylamino) cyclopropanecarboxylic acid

C18H19NO2 (281.1416)


   

(+-)-normecambrine|2a,3,4,5-tetrahydro-2H-spiro[cyclohexa-2,5-diene-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-4-one

(+-)-normecambrine|2a,3,4,5-tetrahydro-2H-spiro[cyclohexa-2,5-diene-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-4-one

C17H15NO3 (281.1052)


   

Spirostaphylotrichin O

Spirostaphylotrichin O

C14H19NO5 (281.1263)


   

Erythrosotidienone

Erythrosotidienone

C17H15NO3 (281.1052)


   

Me ether-(??)-Peyoruvic acid

Me ether-(??)-Peyoruvic acid

C14H19NO5 (281.1263)


   

N-(1-deoxy-D-fructos-1-yl)-L-threonine|N-(1-Desoxy-D-fructos-1-yl)-L-threonin|N-D-Fructose-1-yl-LS-threonin|N-D-fructose-1-yl-LS-threonine

N-(1-deoxy-D-fructos-1-yl)-L-threonine|N-(1-Desoxy-D-fructos-1-yl)-L-threonin|N-D-Fructose-1-yl-LS-threonin|N-D-fructose-1-yl-LS-threonine

C10H19NO8 (281.1111)


   

Reevesianine B|reevesianine-B

Reevesianine B|reevesianine-B

C17H15NO3 (281.1052)


   

Sanjoinine Ia

(9R)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


N-Nornuciferine is a natural product found in Meiogyne monosperma, Neolitsea konishii, and other organisms with data available. N-Nornuciferine is an aporphine alkaloid in lotus leaf that significantly inhibits CYP2D6 with IC50 and Ki of 3.76 and 2.34 μM, respectively. N-Nornuciferine is an aporphine alkaloid in lotus leaf that significantly inhibits CYP2D6 with IC50 and Ki of 3.76 and 2.34 μM, respectively.

   

Lirinidine

4H-Dibenzo(de,g)quinolin-1-ol, 5,6,6a,7-tetrahydro-2-methoxy-6-methyl-, (S)-

C18H19NO2 (281.1416)


Lirinidine is a natural product found in Annona purpurea, Ocotea macrophylla, and other organisms with data available. Lirinidine ((+)-Lirinidine) is an alkaloid isolated from the leaves of?L. tulipifera and has antioxidant and anticancer?activities. Lirinidine exhibits medium ferric reducing power activity and minor radical scavenging activity in vitro. Lirinidine can be used for cosmetic research[1]. Lirinidine ((+)-Lirinidine) is an alkaloid isolated from the leaves of?L. tulipifera and has antioxidant and anticancer?activities. Lirinidine exhibits medium ferric reducing power activity and minor radical scavenging activity in vitro. Lirinidine can be used for cosmetic research[1].

   

Calgam

(2R,3S,4R,5R)-6-[2-(dimethylamino)acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

C10H19NO8 (281.1111)


   

Methylasimilobine

4H-Dibenzo[de,g]quinolin-2-ol, 5,6,6a,7-tetrahydro-1-methoxy-6-methyl-, (6aR)-

C18H19NO2 (281.1416)


O-Nornuciferine is a natural product found in Annona purpurea, Stephania cephalantha, and other organisms with data available.

   

8-Hydroxymirtazapine

8-hydroxy Mirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3712 CONFIDENCE standard compound; INTERNAL_ID 1555

   

10b-Methyl-3,4,5,6,10b,11-hexahydro-2H-4b-aza-chrysene-1,12-dione

"NCGC00160261-01!10b-Methyl-3,4,5,6,10b,11-hexahydro-2H-4b-aza-chrysene-1,12-dione"

C18H19NO2 (281.1416)


   

MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

"MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione"

C15H23NO4 (281.1627)


   

1-Methyladenosine

1-Methyladenosine

C11H15N5O4 (281.1124)


A methyladenosine carrying a methyl substituent at position 1. CONFIDENCE standard compound; INTERNAL_ID 313 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   

2-O-methyladenosine

5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


CONFIDENCE standard compound; INTERNAL_ID 312 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2]. 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2].

   

6-Methyladenosine

6-methylamino-9-beta-delta-Ribofuranosyl-purine

C11H15N5O4 (281.1124)


N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

2-O-Methyladenosine

2-O-Methyladenosine

C11H15N5O4 (281.1124)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 5

   

N6-Methyladenosine

N6-Methyladenosine

C11H15N5O4 (281.1124)


CONFIDENCE standard compound; INTERNAL_ID 307 N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

Isocycloheximide

Isocycloheximide

C15H23NO4 (281.1627)


   
   

L-METHYLADENOSINE

L-METHYLADENOSINE

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

8-OH-Mirtazapine

8-Hydroxymirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; INTERNAL_ID 1555

   

N-Methylasimilobine

N-Methylasimilobine

C18H19NO2 (281.1416)


   

Dainic Acid A

Dainic Acid A

C15H23NO4 (281.1627)


An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a (2E)-6-methylhepta-2,5-dien-2-yl group at position 4. It is produced by the red algal Chondria armata.

   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

C15H23NO4 (281.1627)


   

12,13-Dehydroprolyltryptophanyldiketopiperazine

12,13-Dehydroprolyltryptophanyldiketopiperazine

C16H15N3O2 (281.1164)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

C15H23NO4 (281.1627)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

C15H23NO4 (281.1627)


   

N6-Me-Adenosine

N6-Me-Adenosine

C11H15N5O4 (281.1124)


consensus spectrum

   

N1-Methyladenosine; LC-tDDA; CE10

N1-Methyladenosine; LC-tDDA; CE10

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE20

N1-Methyladenosine; LC-tDDA; CE20

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE30

N1-Methyladenosine; LC-tDDA; CE30

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE10

1-Methyldesoxyguanosine; LC-tDDA; CE10

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE20

1-Methyldesoxyguanosine; LC-tDDA; CE20

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE30

1-Methyldesoxyguanosine; LC-tDDA; CE30

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE40

1-Methyldesoxyguanosine; LC-tDDA; CE40

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE0; CorrDec

N1-Methyladenosine; AIF; CE0; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE10; CorrDec

N1-Methyladenosine; AIF; CE10; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE30; CorrDec

N1-Methyladenosine; AIF; CE30; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE0; MS2Dec

N1-Methyladenosine; AIF; CE0; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE30; MS2Dec

N1-Methyladenosine; AIF; CE30; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE10; MS2Dec

N1-Methyladenosine; AIF; CE10; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE0; CorrDec

1-Methyldesoxyguanosine; AIF; CE0; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE10; CorrDec

1-Methyldesoxyguanosine; AIF; CE10; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE0; MS2Dec

1-Methyldesoxyguanosine; AIF; CE0; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE30; CorrDec

1-Methyldesoxyguanosine; AIF; CE30; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE10; MS2Dec

1-Methyldesoxyguanosine; AIF; CE10; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE30; MS2Dec

1-Methyldesoxyguanosine; AIF; CE30; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE40

N1-Methyladenosine; LC-tDDA; CE40

C11H15N5O4 (281.1124)


   

O6-Methyl-deoxyguanosine

O6-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

N2-Methyl-deoxyguanosine

N2-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

1-Methyl-deoxyguanosine

1-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

N6-Methyl-adenosine

N6-Methyl-adenosine

C11H15N5O4 (281.1124)


   

Pangamic Acid_major

Pangamic Acid_major

C10H19NO8 (281.1111)


   

4-Hydroxyoxprenolol

4-Hydroxyoxprenolol

C15H23NO4 (281.1627)


   

Northiadene

Northiadene

C18H19NS (281.1238)


   

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

C15H23NO4 (281.1627)


   

3-O-Methyladenosine

Adenosine, 3-O-methyl-(7CI,8CI,9CI)

C11H15N5O4 (281.1124)


(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol (Adenosine, 3'-O-methyl- (8CI)(9CI)) is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

Floribundine

16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

Juzirine

1-((4-Hydroxyphenyl)methyl)-6-methoxy-7-isoquinolinol

C17H15NO3 (281.1052)


   

N2-gamma-Glutamyl-p-hydrazinobenzoic acid

N(Sup 2)-(gamma-L-(+)-Glutamyl)-4-carboxyphenylhydrazine

C12H15N3O5 (281.1012)


   

1,4,5,7-Tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl 3-methyl ester

1,4,5,7-Tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl 3-methyl ester

C13H19N3O4 (281.1375)


   

1,3-bis(oxiran-2-ylmethyl)-5-prop-1-en-2-yl-1,3,5-triazinane-2,4,6-trione

1,3-bis(oxiran-2-ylmethyl)-5-prop-1-en-2-yl-1,3,5-triazinane-2,4,6-trione

C12H15N3O5 (281.1012)


   

N-(5-pyridin-3-yl-2H-pyrazolo[3,4-b]pyridin-3-yl)butanamide

N-(5-pyridin-3-yl-2H-pyrazolo[3,4-b]pyridin-3-yl)butanamide

C15H15N5O (281.1277)


   

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

C15H23NO4 (281.1627)


   
   

8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-, benzoate (ester), hydrochloride, (3-exo)- (9CI)

8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-, benzoate (ester), hydrochloride, (3-exo)- (9CI)

C15H20ClNO2 (281.1182)


   

TERT-BUTYL 4-(METHOXYCARBONYL)-3-METHOXYPHENYLCARBAMATE

TERT-BUTYL 4-(METHOXYCARBONYL)-3-METHOXYPHENYLCARBAMATE

C14H19NO5 (281.1263)


   

Benzodepa

Carbamic acid,N-[bis(1-aziridinyl)phosphinyl]-, phenylmethyl ester

C12H16N3O3P (281.0929)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

(7-BENZYLOXYINDOL-1-YL)ACETIC ACID

(7-BENZYLOXYINDOL-1-YL)ACETIC ACID

C17H15NO3 (281.1052)


   

2-(6-phenylmethoxy-1H-indol-3-yl)acetic acid

2-(6-phenylmethoxy-1H-indol-3-yl)acetic acid

C17H15NO3 (281.1052)


   

7-(Benzyloxy)-6-methoxy-4(1H)-quinolinone

7-(Benzyloxy)-6-methoxy-4(1H)-quinolinone

C17H15NO3 (281.1052)


   

methyl 2-(2-benzyl-1,3-dihydroisoindol-1-yl)acetate

methyl 2-(2-benzyl-1,3-dihydroisoindol-1-yl)acetate

C18H19NO2 (281.1416)


   

dioxosilane,3-triethoxysilylpropan-1-amine

dioxosilane,3-triethoxysilylpropan-1-amine

C9H23NO5Si2 (281.1115)


   

N-Desmethyl Sumatriptan

N-Desmethyl Sumatriptan

C13H19N3O2S (281.1198)


   

(R)-2-N-CBZ-AMINO-PENTANE-1,5-DIOL

(R)-2-N-CBZ-AMINO-PENTANE-1,5-DIOL

C14H19NO5 (281.1263)


   

5-(BENZYLOXY)-1H-INDOLE-2-CARBOHYDRAZIDE

5-(BENZYLOXY)-1H-INDOLE-2-CARBOHYDRAZIDE

C16H15N3O2 (281.1164)


   

(3-AMINOSULPHONYL)BENZENEBORONICACID

(3-AMINOSULPHONYL)BENZENEBORONICACID

C16H15N3O2 (281.1164)


   

Piberaline

Piberaline

C17H19N3O (281.1528)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

5,6-Dimethoxy-2-(pyridine-4-yl)methylene-indan-1-one

5,6-Dimethoxy-2-(pyridine-4-yl)methylene-indan-1-one

C17H15NO3 (281.1052)


   

7-bromo-3-hydroxy-2-naphthoic acid

7-bromo-3-hydroxy-2-naphthoic acid

C19H11N3 (281.0953)


   

4-[(1-methylbenzimidazol-2-yl)methylamino]benzoic acid

4-[(1-methylbenzimidazol-2-yl)methylamino]benzoic acid

C16H15N3O2 (281.1164)


   

4-(PIPERAZIN-1-YL)-2-(TRIFLUOROMETHYL)QUINOLINE

4-(PIPERAZIN-1-YL)-2-(TRIFLUOROMETHYL)QUINOLINE

C14H14F3N3 (281.114)


   

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C15H23NO4 (281.1627)


   

(S)-(-)-4-isopropyl-5,5-diphenyl-2-oxazolidinone

(S)-(-)-4-isopropyl-5,5-diphenyl-2-oxazolidinone

C18H19NO2 (281.1416)


   

4-tert-Butylamino-6-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

4-tert-Butylamino-6-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

C12H19N5O3 (281.1488)


   

ANTHRANILICACID,N-BOC-N-METHYL-5-METHOXY

ANTHRANILICACID,N-BOC-N-METHYL-5-METHOXY

C14H19NO5 (281.1263)


   

1-(1-tert-Butoxycarbonyl-pyrrolidin-3-yl)-1H-imidazole-4-carboxylic acid

1-(1-tert-Butoxycarbonyl-pyrrolidin-3-yl)-1H-imidazole-4-carboxylic acid

C13H19N3O4 (281.1375)


   

Pyrovalerone hydrochloride solution

Pyrovalerone hydrochloride solution

C16H24ClNO (281.1546)


   
   

Boc-(R)-3-amino-3-(4-hydroxy-phenyl)- propionic acid

Boc-(R)-3-amino-3-(4-hydroxy-phenyl)- propionic acid

C14H19NO5 (281.1263)


   

(4-HYDROXY-[1,1-BIPHENYL]-4-YL)(PIPERIDIN-1-YL)METHANONE

(4-HYDROXY-[1,1-BIPHENYL]-4-YL)(PIPERIDIN-1-YL)METHANONE

C18H19NO2 (281.1416)


   

1-(boc-amino)-1-(4-chlorophenyl)-cyclobutane

1-(boc-amino)-1-(4-chlorophenyl)-cyclobutane

C15H20ClNO2 (281.1182)


   

tert-butyl N-[2-amino-2-(2-nitrophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(2-nitrophenyl)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Boc-R-3-OH-PHA

Boc-R-3-OH-PHA

C14H19NO5 (281.1263)


   

2,2,3,4,5,5-HEXAMETHYL-3-IMIDAZOLINIUM-1-YLOXY METHYL SULFATE

2,2,3,4,5,5-HEXAMETHYL-3-IMIDAZOLINIUM-1-YLOXY METHYL SULFATE

C10H21N2O5S (281.1171)


   

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

C17H20BNO2 (281.1587)


   

acetic acid; 2-[(2-aminoacetyl)amino]-3-phenyl-propanamide

acetic acid; 2-[(2-aminoacetyl)amino]-3-phenyl-propanamide

C13H19N3O4 (281.1375)


   

trimetozine

trimetozine

C14H19NO5 (281.1263)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

(2S,4S)-1-BENZYL-2-METHY-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

(2S,4S)-1-BENZYL-2-METHY-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

C14H16FNO4 (281.1063)


   

4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C13H17BClNO3 (281.099)


   

2-[4-(dimethylamino)phenyl]-3H-benzimidazole-5-carboxylic acid

2-[4-(dimethylamino)phenyl]-3H-benzimidazole-5-carboxylic acid

C16H15N3O2 (281.1164)


   

Benzyl 4-[Methoxy(Methyl)aMino]-4-oxobutanoate

Benzyl 4-[Methoxy(Methyl)aMino]-4-oxobutanoate

C14H16FNO4 (281.1063)


   

2-(2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

2-(2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

C17H15NO3 (281.1052)


   

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   

2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)-N-phenylacetamide

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-PHENYL-ACETAMIDE

C16H15N3O2 (281.1164)


   

(1S,3S,5S)-2-Azabicyclo[3,3,0]octane-3-carborylic acid benzyl ester hydrochloride

(1S,3S,5S)-2-Azabicyclo[3,3,0]octane-3-carborylic acid benzyl ester hydrochloride

C15H20ClNO2 (281.1182)


   

(S)-Ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

(S)-Ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

C18H19NO2 (281.1416)


   

N,N-DIPROPYL-2,6-DINITRO-PARA-TOLUIDINE

N,N-DIPROPYL-2,6-DINITRO-PARA-TOLUIDINE

C13H19N3O4 (281.1375)


   

TERT-BUTYL (4-IODO-5-METHOXYPYRIDIN-3-YL)-METHYLCARBAMATE

TERT-BUTYL (4-IODO-5-METHOXYPYRIDIN-3-YL)-METHYLCARBAMATE

C13H19N3O4 (281.1375)


   

2-Phenylpyridine-4-boronic acid pinacol ester

2-Phenylpyridine-4-boronic acid pinacol ester

C17H20BNO2 (281.1587)


   

Boc-(S)-3-Amino-3-(2-hydroxy-phenyl)-propionic acid

Boc-(S)-3-Amino-3-(2-hydroxy-phenyl)-propionic acid

C14H19NO5 (281.1263)


   

tert-butyl (3R)-3-(4-fluorophenoxy)pyrrolidine-1-carboxylate

tert-butyl (3R)-3-(4-fluorophenoxy)pyrrolidine-1-carboxylate

C15H20FNO3 (281.1427)


   

(Z)-2-BENZAMIDO-3-(O-TOLYL)ACRYLIC ACID

(Z)-2-BENZAMIDO-3-(O-TOLYL)ACRYLIC ACID

C17H15NO3 (281.1052)


   

(3-Chloro-4-(cyclohexylcarbamoyl)phenyl)boronic acid

(3-Chloro-4-(cyclohexylcarbamoyl)phenyl)boronic acid

C13H17BClNO3 (281.099)


   

(4-Chloro-3-(cyclohexylcarbamoyl)phenyl)boronic acid

(4-Chloro-3-(cyclohexylcarbamoyl)phenyl)boronic acid

C13H17BClNO3 (281.099)


   

Boc-Ser(Bzl)-ol

Boc-Ser(Bzl)-ol

C15H23NO4 (281.1627)


   

4-chloro-N-[1-(N-hydroxycarbamimidoyl)cyclopentyl]benzamide

4-chloro-N-[1-(N-hydroxycarbamimidoyl)cyclopentyl]benzamide

C13H16ClN3O2 (281.0931)


   
   

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

C17H19N3O (281.1528)


   

dexindoprofen

dexindoprofen

C17H15NO3 (281.1052)


   

1-[(Benzyloxy)carbonyl]-3-fluoro-3-piperidinecarboxylic acid

1-[(Benzyloxy)carbonyl]-3-fluoro-3-piperidinecarboxylic acid

C14H16FNO4 (281.1063)


   

glutaric acid-2-methylamino-5-nitromonoanilide

glutaric acid-2-methylamino-5-nitromonoanilide

C12H15N3O5 (281.1012)


   

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

C17H19N3O (281.1528)


   

di-beta-d-xylopyranosylamine

di-beta-d-xylopyranosylamine

C10H19NO8 (281.1111)


   

Methyl 1-benzhydrylazetidine-3-carboxylate

Methyl 1-benzhydrylazetidine-3-carboxylate

C18H19NO2 (281.1416)


   

3-benzyl-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

3-benzyl-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

C18H19NO2 (281.1416)


   

N-Boc-3-hydroxy-L-phenylalanine

N-Boc-3-hydroxy-L-phenylalanine

C14H19NO5 (281.1263)


   

2-(4-DIMETHYLAMINO-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID

2-(4-DIMETHYLAMINO-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID

C16H15N3O2 (281.1164)


   

2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]pyridine-3-carboxylic acid

2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]pyridine-3-carboxylic acid

C13H19N3O4 (281.1375)


   

H-Asp(OBut)-ObutHCL

H-Asp(OBut)-ObutHCL

C12H24ClNO4 (281.1394)


   

(3-CHLORO-PYRIDIN-2-YL)-METHYL AMINE DIHYDROCHLORIDE

(3-CHLORO-PYRIDIN-2-YL)-METHYL AMINE DIHYDROCHLORIDE

C18H19NO2 (281.1416)


   

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

C16H24ClNO (281.1546)


   

4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHOXY)BENZOIC ACID

4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHOXY)BENZOIC ACID

C14H19NO5 (281.1263)


   

2-(7-phenylmethoxy-1H-indol-3-yl)acetic acid

2-(7-phenylmethoxy-1H-indol-3-yl)acetic acid

C17H15NO3 (281.1052)


   

Roxadimate

ethyl 4-[bis(2-hydroxypropyl)amino]benzoate

C15H23NO4 (281.1627)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

Potassium guaiacolsulfonate hemihydrate

Potassium guaiacolsulfonate hemihydrate

C7H8O5S.1/2H2O.K (281.14)


   

Boc-D-threo-3-phenylserine

Boc-D-threo-3-phenylserine

C14H19NO5 (281.1263)


   

2-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZAMIDE

2-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZAMIDE

C13H17BClNO3 (281.099)


   

11-Maleimidoundecanoic acid

11-Maleimidoundecanoic acid

C15H23NO4 (281.1627)


   

1-Benzyl-4-Phenyl-Pyrrolidine-3-Carboxylic Acid

1-Benzyl-4-Phenyl-Pyrrolidine-3-Carboxylic Acid

C18H19NO2 (281.1416)


   

5-benzyloxyindole-3-acetic acid

5-benzyloxyindole-3-acetic acid

C17H15NO3 (281.1052)


   

(s)-boc-beta-tyr-oh

(s)-boc-beta-tyr-oh

C14H19NO5 (281.1263)


   

Lin28-IN-1632

Lin28-IN-1632

C15H15N5O (281.1277)


   

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

C15H23NO4 (281.1627)


   
   

9H-Fluoren-9-ylmethyl (2-oxoethyl)carbamate

9H-Fluoren-9-ylmethyl (2-oxoethyl)carbamate

C17H15NO3 (281.1052)


   

1H-Pyrrole-2-propanoicacid, 4-(ethoxycarbonyl)-3,5-dimethyl-b-oxo-, ethyl ester

1H-Pyrrole-2-propanoicacid, 4-(ethoxycarbonyl)-3,5-dimethyl-b-oxo-, ethyl ester

C14H19NO5 (281.1263)


   

tert-butyl 3-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate

tert-butyl 3-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate

C12H18F3NO3 (281.1239)


   

tert-Butyl 4-(2,2,2-trifluoro-acetyl)piperidin-1-carboxylate

tert-Butyl 4-(2,2,2-trifluoro-acetyl)piperidin-1-carboxylate

C12H18F3NO3 (281.1239)


   

DIETHYL 2-[[(1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]METHYLIDENE]MALONATE

DIETHYL 2-[[(1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]METHYLIDENE]MALONATE

C13H19N3O4 (281.1375)


   

(S)-3-(3-HYDROXY-4-METHOXYPHENYL)-BETA-ALANINE

(S)-3-(3-HYDROXY-4-METHOXYPHENYL)-BETA-ALANINE

C17H15NO3 (281.1052)


   

4-(4-Pyridinyl)phenylboronic acid pinacol ester

4-(4-Pyridinyl)phenylboronic acid pinacol ester

C17H20BNO2 (281.1587)


   

1-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-2-(QUINOXALIN-6-YL)ETHANONE

1-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-2-(QUINOXALIN-6-YL)ETHANONE

C16H12FN3O (281.0964)


   

3,3-DIMETHYL-1-TOSYLPIPERIDIN-4-ONE

3,3-DIMETHYL-1-TOSYLPIPERIDIN-4-ONE

C14H19NO3S (281.1086)


   

6-(BENZYLOXY)-7-METHOXYQUINOLIN-4(1H)-ONE

6-(BENZYLOXY)-7-METHOXYQUINOLIN-4(1H)-ONE

C17H15NO3 (281.1052)


   

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

C17H20BNO2 (281.1587)


   

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one,hydrochloride

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one,hydrochloride

C15H20ClNO2 (281.1182)


   

ethyl 4-(2-methylimidazo[4,5-c]pyridin-1-yl)benzoate

ethyl 4-(2-methylimidazo[4,5-c]pyridin-1-yl)benzoate

C16H15N3O2 (281.1164)


   

2-(1-Oxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanoic acid

2-(1-Oxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanoic acid

C17H15NO3 (281.1052)


   

(2S,4R)-1-BENZYL-2-METHYL-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

(2S,4R)-1-BENZYL-2-METHYL-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

C14H16FNO4 (281.1063)


   

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

C17H19N3O (281.1528)


   

tert-butyl N-[2-amino-2-(4-nitrophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(4-nitrophenyl)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Tolperisone hydrochloride

Tolperisone hydrochloride

C16H24ClNO (281.1546)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant D002491 - Central Nervous System Agents

   

(2R,3S)-Boc-3-Phenylisoserine

(2R,3S)-Boc-3-Phenylisoserine

C14H19NO5 (281.1263)


   

methyl 4-phenylmethoxy-1H-indole-2-carboxylate

methyl 4-phenylmethoxy-1H-indole-2-carboxylate

C17H15NO3 (281.1052)


   

2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl-3-carboxylic acid n-hydroxysuccinimide ester

2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl-3-carboxylic acid n-hydroxysuccinimide ester

C13H17N2O5 (281.1137)


   

TERT-BUTOXYCARBONYLAMINO-(2-METHOXY-PHENYL)-ACETIC ACID

TERT-BUTOXYCARBONYLAMINO-(2-METHOXY-PHENYL)-ACETIC ACID

C14H19NO5 (281.1263)


   

Ofornine

piperidin-1-yl-[2-(pyridin-4-ylamino)phenyl]methanone

C17H19N3O (281.1528)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

   

5-piperazin-1-yl-1-benzofuran-2-carboxamide,hydrochloride

5-piperazin-1-yl-1-benzofuran-2-carboxamide,hydrochloride

C13H16ClN3O2 (281.0931)


   

5-Tert-Butyl3-Ethyl4,6-Dihydropyrrolo[3,4-C]Pyrazole-3,5(1H)-Dicarboxylate

5-Tert-Butyl3-Ethyl4,6-Dihydropyrrolo[3,4-C]Pyrazole-3,5(1H)-Dicarboxylate

C13H19N3O4 (281.1375)


   

(6-Chloro-1H-benzoimidazol-2-ylmethyl)-carbamic acid tert-butyl ester

(6-Chloro-1H-benzoimidazol-2-ylmethyl)-carbamic acid tert-butyl ester

C13H16ClN3O2 (281.0931)


   

5-Formyl-3-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(1,1-dimethylethyl) 4-ethyl ester

5-Formyl-3-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(1,1-dimethylethyl) 4-ethyl ester

C14H19NO5 (281.1263)


   

2-((tert-butoxycarbonyl)amino)-2-(4-methoxyphenyl)acetic acid

2-((tert-butoxycarbonyl)amino)-2-(4-methoxyphenyl)acetic acid

C14H19NO5 (281.1263)


   

3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE

3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE

C18H16FNO (281.1216)


   

methanesulfonic acid 5-boc-amino-pentyl ester

methanesulfonic acid 5-boc-amino-pentyl ester

C11H23NO5S (281.1297)


   

(R)-(+)-4-Isopropyl-5,5-diphenyl-2-oxazolidinone

(R)-(+)-4-Isopropyl-5,5-diphenyl-2-oxazolidinone

C18H19NO2 (281.1416)


   

4-o-pivaloyl-3-hydroxy-l-phenylalanine

4-o-pivaloyl-3-hydroxy-l-phenylalanine

C14H19NO5 (281.1263)


   

2-benzoyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid

2-benzoyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid

C17H15NO3 (281.1052)


   

1-(4-METHYLPHENYL)-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE

1-(4-METHYLPHENYL)-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE

C18H19NO2 (281.1416)


   

Boc-(R)-2-Methoxy-phenylglycine

Boc-(R)-2-Methoxy-phenylglycine

C14H19NO5 (281.1263)


   

(S,S)-2-Azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride

(S,S)-2-Azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride

C15H20ClNO2 (281.1182)


   

METHYL BETA-NEURAMINIC ACID

METHYL BETA-NEURAMINIC ACID

C10H19NO8 (281.1111)


   
   

2-Propenoic acid,3-[4-[[(4-methoxyphenyl)methylene]amino]phenyl]-

2-Propenoic acid,3-[4-[[(4-methoxyphenyl)methylene]amino]phenyl]-

C17H15NO3 (281.1052)


   

TERT-BUTYL 5-(2-CHLOROETHYL)INDOLINE-1-CARBOXYLATE

TERT-BUTYL 5-(2-CHLOROETHYL)INDOLINE-1-CARBOXYLATE

C15H20ClNO2 (281.1182)


   

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H20BNO2 (281.1587)


   

6-(4-aminophenyl)-4-ethoxypyrido[3,2-d]pyrimidin-2-amine

6-(4-aminophenyl)-4-ethoxypyrido[3,2-d]pyrimidin-2-amine

C15H15N5O (281.1277)


   

Methyl 4-(benzyloxy)-1H-indole-6-carboxylate

Methyl 4-(benzyloxy)-1H-indole-6-carboxylate

C17H15NO3 (281.1052)


   

(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-HYDROXYPHENYL)PROPANOIC ACID

(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-HYDROXYPHENYL)PROPANOIC ACID

C14H19NO5 (281.1263)


   

2-C-Methyladenosine

2-C-Methyladenosine

C11H15N5O4 (281.1124)


2'-C-Methyladenosine is an inhibitor of hepatitis C virus (HCV) replication. 2'-C-Methyladenosine inhibits HCV replicon and NS5B-catalyzed RNA synthesis with IC50 values of 0.3μM and 1.9 μM, respectively. 2'-C-Methyladenosine also potently inhibits LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis[1][2].

   

(4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER

(4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER

C14H16FNO4 (281.1063)


   

3,4-diphenylisoquinoline

3,4-diphenylisoquinoline

C21H15N (281.1204)


   

NU7026

2-(Morpholin-4-yl)-benzo[h]chromen-4-one

C17H15NO3 (281.1052)


   
   

1-TERT-BUTYL2-METHYL(2S,4R)-4-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE

1-TERT-BUTYL2-METHYL(2S,4R)-4-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE

C11H20ClNO5 (281.103)


   
   

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   
   

boc-(s)-3-amino-3-(3-hydroxy-phenyl)-propionic acid

boc-(s)-3-amino-3-(3-hydroxy-phenyl)-propionic acid

C14H19NO5 (281.1263)


   

2-Chloro-1-(6-methoxy-2,2,4-trimethyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone

2-Chloro-1-(6-methoxy-2,2,4-trimethyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone

C15H20ClNO2 (281.1182)


   

5-(Benzyloxy)-6-methoxy-1H-indole-3-carbaldehyde

5-(Benzyloxy)-6-methoxy-1H-indole-3-carbaldehyde

C17H15NO3 (281.1052)


   

3-[(2R)-1-acetyl-2-pyrrolidinyl]--aMino-5-isoxazolepropanoic acid Methyl ester

3-[(2R)-1-acetyl-2-pyrrolidinyl]--aMino-5-isoxazolepropanoic acid Methyl ester

C13H19N3O4 (281.1375)


   

2-Benzyl-2,3-dihydro-1H-isoindole-1-carboxylic acid ethyl ester

2-Benzyl-2,3-dihydro-1H-isoindole-1-carboxylic acid ethyl ester

C18H19NO2 (281.1416)


   

N-(L-ALANYL)-2-AMINOACRIDONE FOR FLUORE

N-(L-ALANYL)-2-AMINOACRIDONE FOR FLUORE

C16H15N3O2 (281.1164)


   

(4R,8S)-8-(3-(difluoroMethyl)phenyl)-4-Methyl-2-Methylene-6-oxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-iuM-8-uide

(4R,8S)-8-(3-(difluoroMethyl)phenyl)-4-Methyl-2-Methylene-6-oxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-iuM-8-uide

C13H14BF2NO3 (281.1035)


   

ethyl 4-(cyclopentylamino)-2-methylsulfanylpyrimidine-5-carboxylate

ethyl 4-(cyclopentylamino)-2-methylsulfanylpyrimidine-5-carboxylate

C13H19N3O2S (281.1198)


   
   

tert-butyl N-[2-(2-nitroanilino)ethyl]carbamate

tert-butyl N-[2-(2-nitroanilino)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Methyl 5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate

Methyl 5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate

C13H17BFNO4 (281.1235)


   

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

C17H19N3O (281.1528)


   

TRANS-1-BENZYL-4-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID

TRANS-1-BENZYL-4-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID

C18H19NO2 (281.1416)


   

3-amino-4-methoxy-9-phenyl-5,8,10-trioxabicyclo[4.4.0]decan-2-ol

3-amino-4-methoxy-9-phenyl-5,8,10-trioxabicyclo[4.4.0]decan-2-ol

C14H19NO5 (281.1263)


   

[2-[(tert-butoxycarbonyl)amino]-3-methoxyphenyl]acetic acid

[2-[(tert-butoxycarbonyl)amino]-3-methoxyphenyl]acetic acid

C14H19NO5 (281.1263)


   

3-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoic acid

3-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoic acid

C14H19NO5 (281.1263)


   

cladribine related compound a (20 mg) (2-methoxy-2-deoxyadenosine)

cladribine related compound a (20 mg) (2-methoxy-2-deoxyadenosine)

C11H15N5O4 (281.1124)


   

Boc-D-tyrosine

Boc-D-tyrosine

C14H19NO5 (281.1263)


   

3-Borono-5-((tert-butoxycarbonyl)amino)benzoic acid

3-Borono-5-((tert-butoxycarbonyl)amino)benzoic acid

C12H16BNO6 (281.1071)


   

2-ACETAMIDO-3-(4-BIPHENYL)ACRYLIC ACID

2-ACETAMIDO-3-(4-BIPHENYL)ACRYLIC ACID

C17H15NO3 (281.1052)


   

Methyl 6-(benzyloxy)-1H-indole-2-carboxylate

Methyl 6-(benzyloxy)-1H-indole-2-carboxylate

C17H15NO3 (281.1052)


   

2-(Adamantan-1-yl)isoindoline-1,3-dione

2-(Adamantan-1-yl)isoindoline-1,3-dione

C18H19NO2 (281.1416)


   

5-[(4-Methylpiperazin-1-yl)sulfonyl]indoline

5-[(4-Methylpiperazin-1-yl)sulfonyl]indoline

C13H19N3O2S (281.1198)


   
   

Talsaclidine fumarate

Talsaclidine fumarate

C14H19NO5 (281.1263)


C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist

   

Tetrydamine maleate

Tetrydamine maleate

C13H19N3O4 (281.1375)


   

3-Methyladenosine

3-Methyladenosine

C11H15N5O4 (281.1124)


   

Mirtazapine N-Oxide

Mirtazapine N-Oxide

C17H19N3O (281.1528)


   

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

C18H19NO2 (281.1416)


D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

   

5-(2-Amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

5-(2-Amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C11H15N5O4 (281.1124)


   

2,3,3-Triphenylacrylonitrile

Benzeneacetonitrile, a-(diphenylmethylene)-

C21H15N (281.1204)


   

N-cyclooctyl-4-methylbenzenesulfonamide

N-cyclooctyl-4-methylbenzenesulfonamide

C15H23NO2S (281.1449)


   

(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenylpropanoic acid

(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenylpropanoic acid

C17H15NO3 (281.1052)


   

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

C17H19N3O (281.1528)


   

2-(2-Oxolanylmethyl)benzo[de]isoquinoline-1,3-dione

2-(2-Oxolanylmethyl)benzo[de]isoquinoline-1,3-dione

C17H15NO3 (281.1052)


   

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

C17H19N3O (281.1528)


   

6-Methylaminopurine arabinoside

6-Methylaminopurine arabinoside

C11H15N5O4 (281.1124)


   

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

C17H19N3O (281.1528)


   

5-Methyl-3-phenyl-7-(prop-2-enylthio)pyrazolo[1,5-a]pyrimidine

5-Methyl-3-phenyl-7-(prop-2-enylthio)pyrazolo[1,5-a]pyrimidine

C16H15N3S (281.0987)


   

1-Piperidinecarboxylic acid (4-phenylphenyl) ester

1-Piperidinecarboxylic acid (4-phenylphenyl) ester

C18H19NO2 (281.1416)


   

N-[2-(3-pyridinyl)-1,3-benzoxazol-5-yl]butanamide

N-[2-(3-pyridinyl)-1,3-benzoxazol-5-yl]butanamide

C16H15N3O2 (281.1164)


   

4-(2-fluorophenyl)-N-(2-methylbut-3-yn-2-yl)benzamide

4-(2-fluorophenyl)-N-(2-methylbut-3-yn-2-yl)benzamide

C18H16FNO (281.1216)


   

8-Methyladenosine

8-Methyladenosine

C11H15N5O4 (281.1124)


   

5-hydroxy-N,N-dimethyl-2-phenyl-1-benzofuran-3-carboxamide

5-hydroxy-N,N-dimethyl-2-phenyl-1-benzofuran-3-carboxamide

C17H15NO3 (281.1052)


   

3-(3,5-Dimethylanilino)-5-(2-furanyl)-1-cyclohex-2-enone

3-(3,5-Dimethylanilino)-5-(2-furanyl)-1-cyclohex-2-enone

C18H19NO2 (281.1416)


   

3-(4-Methylphenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

3-(4-Methylphenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

C16H15N3S (281.0987)


   

4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butanoic acid hydrochloride

4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butanoic acid hydrochloride

C15H20ClNO2 (281.1182)


   

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

C17H19N3O (281.1528)


   

O-Mannopyranosylthreonine

O-Mannopyranosylthreonine

C10H19NO8 (281.1111)


   

8-Hydroxymirtazapine, (R)-

8-Hydroxymirtazapine, (R)-

C17H19N3O (281.1528)


   

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

C17H19N3O (281.1528)


   

2-Hydroxymethyl-5-(7-methylamino-3H-pyrazolo[4,3-D]pyrimidin-3-YL)-tetrahydro-furan-3,4-diol

2-Hydroxymethyl-5-(7-methylamino-3H-pyrazolo[4,3-D]pyrimidin-3-YL)-tetrahydro-furan-3,4-diol

C11H15N5O4 (281.1124)


   

(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid

(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid

C17H15NO3 (281.1052)


   

4-Imidazolmethylene-5-Imidazolone Chromophore

4-Imidazolmethylene-5-Imidazolone Chromophore

C11H15N5O4 (281.1124)


   

PENDIMETHALIN

PENDIMETHALIN

C13H19N3O4 (281.1375)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Pridopidine

Pridopidine

C15H23NO2S (281.1449)


C78272 - Agent Affecting Nervous System Pridopidine, a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist. Pridopidine exerts high affinity towards sigma 1 receptor (S1R) with Ki between 70 and 80 nM, which is ~100× higher than its affinity toward D2R.

   

LUFIRONIL

LUFIRONIL

C13H19N3O4 (281.1375)


C471 - Enzyme Inhibitor

   

3153-55-7

4H-Dibenzo(de,g)quinolin-2-ol, 5,6,6a,7-tetrahydro-1-methoxy-6-methyl-, (R)-

C18H19NO2 (281.1416)


   

N(6)-methylformycin A

N(6)-methylformycin A

C11H15N5O4 (281.1124)


   

dihydroxyphaseic acid

dihydroxyphaseic acid

C15H21O5- (281.1389)


   

(Z)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid

(Z)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid

C18H19NO2 (281.1416)


D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

   

1-Propanamine, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-N-methyl-

1-Propanamine, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-N-methyl-

C18H19NS (281.1238)


   

(2E,4E)-5-(3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl)-3-methylpenta-2,4-dienoate

(2E,4E)-5-(3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl)-3-methylpenta-2,4-dienoate

C15H21O5- (281.1389)


   

Pisoniamide

Pisoniamide

C18H19NO2 (281.1416)


A member of the class of cinnamamides that is trans-cinnamamide substituted by a 2-(4-methoxyphenyl)ethyl group at the nitrogen atom. It has been isolated from Pisonia aculeata.

   

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine

C16H15N3O2 (281.1164)


   

6-methylformycin A

6-methylformycin A

C11H15N5O4 (281.1124)


   

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

C16H24ClNO (281.1546)


   

2-[2-(4-Methylphenoxy)ethyl]isoindole-1,3-dione

2-[2-(4-Methylphenoxy)ethyl]isoindole-1,3-dione

C17H15NO3 (281.1052)


   

4-butyl-3-(5-propan-2-yl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

4-butyl-3-(5-propan-2-yl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

C13H19N3S2 (281.102)


   

8-(3-ethoxypropylamino)-1,3-dimethyl-7H-purine-2,6-dione

8-(3-ethoxypropylamino)-1,3-dimethyl-7H-purine-2,6-dione

C12H19N5O3 (281.1488)


   

2-(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-4,6-dimethyl-3-pyridinecarbonitrile

2-(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-4,6-dimethyl-3-pyridinecarbonitrile

C16H15N3O2 (281.1164)


   

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

C17H19N3O (281.1528)


   

N-[(E)-Furan-2-ylmethylideneamino]-8-methoxy-2-methylquinolin-4-amine

N-[(E)-Furan-2-ylmethylideneamino]-8-methoxy-2-methylquinolin-4-amine

C16H15N3O2 (281.1164)


   

R-(-)-norushinsunine

R-(-)-norushinsunine

C17H15NO3 (281.1052)


A natural product found in Annona glabra.

   

N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)butanamide

N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)butanamide

C16H15N3O2 (281.1164)


   

6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-ethyl-1H-pyrimidine-2,4-dione

6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-ethyl-1H-pyrimidine-2,4-dione

C13H19N3O4 (281.1375)


   

(E)-2-Cyano-3-(1-methyl-5-p-tolyl-1H-pyrrol-2-yl)-thioacrylamide

(E)-2-Cyano-3-(1-methyl-5-p-tolyl-1H-pyrrol-2-yl)-thioacrylamide

C16H15N3S (281.0987)


   

4-(4-Chlorophenoxy)-1-(1-piperidinyl)-1-butanone

4-(4-Chlorophenoxy)-1-(1-piperidinyl)-1-butanone

C15H20ClNO2 (281.1182)


   

1-(1-Oxo-2-thiophen-2-ylethyl)-4-piperidinecarboxylic acid ethyl ester

1-(1-Oxo-2-thiophen-2-ylethyl)-4-piperidinecarboxylic acid ethyl ester

C14H19NO3S (281.1086)


   

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

C17H19N3O (281.1528)


   

5-(3-Phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

5-(3-Phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

C16H15N3O2 (281.1164)


   

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

C17H19N3O (281.1528)


   

3-[2-(3-Phenoxypropyl)-5-tetrazolyl]pyridine

3-[2-(3-Phenoxypropyl)-5-tetrazolyl]pyridine

C15H15N5O (281.1277)


   

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

C17H19N3O (281.1528)


   

1-Ethyl-2-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3-indole]one

1-Ethyl-2-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3-indole]one

C16H15N3O2 (281.1164)


   

4-[[[2-(Isopropyloxy)phenoxy]carbonyl]amino]butanoic acid

4-[[[2-(Isopropyloxy)phenoxy]carbonyl]amino]butanoic acid

C14H19NO5 (281.1263)


   

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

fumisoquin A cation

fumisoquin A cation

C13H17N2O5+ (281.1137)


   

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

C13H21N4O3+ (281.1614)


   

(1E)-1-[(3-chlorophenyl)hydrazinylidene]-1-morpholin-4-ylpropan-2-one

(1E)-1-[(3-chlorophenyl)hydrazinylidene]-1-morpholin-4-ylpropan-2-one

C13H16ClN3O2 (281.0931)


   

3-Hydroxy-4,5-diphenylpiperidine-2,6-dione

3-Hydroxy-4,5-diphenylpiperidine-2,6-dione

C17H15NO3 (281.1052)


   

N1-Methyl-2-deoxyguanosine

N1-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


   

(11bS)-11b-methyl-3,4,6,7,11b,12-hexahydro-1H-isoquino[2,1-a]quinoline-1,13(2H)-dione

(11bS)-11b-methyl-3,4,6,7,11b,12-hexahydro-1H-isoquino[2,1-a]quinoline-1,13(2H)-dione

C18H19NO2 (281.1416)


   

D-Gluconic acid, 6-ester with N,N-dimethylglycine

D-Gluconic acid, 6-ester with N,N-dimethylglycine

C10H19NO8 (281.1111)


   

7-Acetylaminoflavanone

7-Acetylaminoflavanone

C17H15NO3 (281.1052)


   

6-Acetylaminoflavanone

6-Acetylaminoflavanone

C17H15NO3 (281.1052)


   

2-Acetylaminoflavanone

2-Acetylaminoflavanone

C17H15NO3 (281.1052)


   

6-Methyl-4-(N,N-dimethylamino)flavanone

6-Methyl-4-(N,N-dimethylamino)flavanone

C18H19NO2 (281.1416)


   

2-Amino-4,8-bis(methoxymethyl)azulene-1,3-dicarbonitrile

2-Amino-4,8-bis(methoxymethyl)azulene-1,3-dicarbonitrile

C16H15N3O2 (281.1164)


   

DIMINAZENE

DIMINAZENE

C14H15N7 (281.1389)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

O(6)-Methyl-2-deoxyguanosine

O(6)-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


O6-Methyldeoxy guanosine; DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

Acetoxyacetylaminofluorene

Acetoxyacetylaminofluorene

C17H15NO3 (281.1052)


D009676 - Noxae > D000477 - Alkylating Agents

   

(E)-2-Hydroxy-N-desmethyldoxepin

(E)-2-Hydroxy-N-desmethyldoxepin

C18H19NO2 (281.1416)


   

N-(1-Deoxy-1-fructosyl)threonine

N-(1-Deoxy-1-fructosyl)threonine

C10H19NO8 (281.1111)


   

N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine

N2-(gamma-Glutamyl)-4-carboxyphenylhydrazine

C12H15N3O5 (281.1012)


   

fumisoquin A(1+)

fumisoquin A(1+)

C13H17N2O5 (281.1137)


A primary ammonium ion that is the conjugate acid of fumisoquin A, obtained from the protonation of the amino group. Major microspecies at pH 7.3.

   
   

cordysinin B

cordysinin B

C11H15N5O4 (281.1124)


A member of the class of adenosines that is adenosine in which the hydroxy group at position 2 is replaced by a methoxy group. It has been isolated from the mycelia of Cordyceps sinensis.

   
   

Methyladenosine

Methyladenosine

C11H15N5O4 (281.1124)


   

O-Methyladenosine

O-Methyladenosine

C11H15N5O4 (281.1124)


   

2’-Deoxy-N1-methylguanosine

2’-Deoxy-N1-methylguanosine

C11H15N5O4 (281.1124)


2’-Deoxy-N1-methylguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

PPARα/γ agonist 1

PPARα/γ agonist 1

C18H19NO2 (281.1416)


PPARα/γ agonist 1 is a potent and dual PPARα/γ partial agonist with EC50 values of 28 nM and 69 nM for PPARα and PPARγ, respectively. PPARα/γ agonist 1 is a promising prototype for dyslipidemia and diabetes research[1].

   

(1r,5s,16s)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,5s,16s)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


   

(9s)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

(9s)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(methoxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(methoxymethyl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


   

5,11-dihydroxy-9-methoxy-8-methyl-2-[(1z)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

5,11-dihydroxy-9-methoxy-8-methyl-2-[(1z)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

2-(4-hydroxy-3-methoxyphenyl)-1-methylquinolin-4-one

2-(4-hydroxy-3-methoxyphenyl)-1-methylquinolin-4-one

C17H15NO3 (281.1052)


   

(9r,12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-9-ol

(9r,12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-9-ol

C17H15NO3 (281.1052)


   

5,5,17-trimethyl-6,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,12(16),13-hexaen-11-one

5,5,17-trimethyl-6,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,12(16),13-hexaen-11-one

C17H15NO3 (281.1052)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

C17H15NO3 (281.1052)


   

2,4-dihydroxy-n-[(2s)-1-methoxy-1-oxopropan-2-yl]-3,5,6-trimethylbenzenecarboximidic acid

2,4-dihydroxy-n-[(2s)-1-methoxy-1-oxopropan-2-yl]-3,5,6-trimethylbenzenecarboximidic acid

C14H19NO5 (281.1263)


   

(12'r)-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

(12'r)-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

C17H15NO3 (281.1052)


   

2-[(4e,6z)-3-oxonona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(4e,6z)-3-oxonona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H19NO2 (281.1416)


   

5'-o-methyladenosine

NA

C11H15N5O4 (281.1124)


{"Ingredient_id": "HBIN011859","Ingredient_name": "5'-o-methyladenosine","Alias": "NA","Ingredient_formula": "C11H15N5O4","Ingredient_Smile": "COCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O","Ingredient_weight": "281.27 g/mol","OB_score": "22.44657067","CAS_id": "NA","SymMap_id": "SMIT08694","TCMID_id": "NA","TCMSP_id": "MOL007215","TCM_ID_id": "NA","PubChem_id": "6480505","DrugBank_id": "NA"}

   

β- glucosidase

NA

C10H19NO8 (281.1111)


{"Ingredient_id": "HBIN018132","Ingredient_name": "\u03b2- glucosidase","Alias": "NA","Ingredient_formula": "C10H19NO8","Ingredient_Smile": "C(C1C(C(C(C(O1)OCC(CO)NC=O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38177","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

diphenylmethyl 3,3-dimethylaziridine-2-carboxylate

diphenylmethyl 3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

(9r)-5-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

(9r)-5-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

C18H19NO2 (281.1416)


   

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-ethyl-4-sulfanyloxolan-3-ol

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-ethyl-4-sulfanyloxolan-3-ol

C11H15N5O2S (281.0946)


   

3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazole-2,6-diol

3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazole-2,6-diol

C18H19NO2 (281.1416)


   

diphenylmethyl (2s)-3,3-dimethylaziridine-2-carboxylate

diphenylmethyl (2s)-3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]propanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]propanamide

C13H19N3O4 (281.1375)


   

15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-8-one

15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-8-one

C17H15NO3 (281.1052)


   

(1s,2s)-1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

(1s,2s)-1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

C11H15N5O4 (281.1124)


   

6-methyl-1-(3-methylbut-2-en-1-yl)-9h-carbazole-2,7-diol

6-methyl-1-(3-methylbut-2-en-1-yl)-9h-carbazole-2,7-diol

C18H19NO2 (281.1416)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}propanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}propanamide

C13H19N3O4 (281.1375)


   

(12r,13s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

(12r,13s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

C17H15NO3 (281.1052)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

C17H15NO3 (281.1052)


   

(12bs)-10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

(12bs)-10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C18H19NO2 (281.1416)


   

n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

C18H19NO2 (281.1416)


   

(14s,15s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,12(20),16,18-hexaen-15-ol

(14s,15s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,12(20),16,18-hexaen-15-ol

C17H15NO3 (281.1052)


   

1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

C11H15N5O4 (281.1124)


   

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

C17H15NO3 (281.1052)


   

(4r,5r,6r,9r,10r)-4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

(4r,5r,6r,9r,10r)-4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-9-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-9-ol

C17H15NO3 (281.1052)


   

3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

C17H15NO3 (281.1052)


   

(9s)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

(9s)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C18H19NO2 (281.1416)


   

15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

11-methoxy-5,5-dimethyl-6,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,11,13,16-heptaene

11-methoxy-5,5-dimethyl-6,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,11,13,16-heptaene

C17H15NO3 (281.1052)


   

4,5-dimethoxy-9λ⁵-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-9-ylium-14-olate

4,5-dimethoxy-9λ⁵-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-9-ylium-14-olate

C17H15NO3 (281.1052)


   

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

C17H15NO3 (281.1052)


   

2,4-dihydroxy-n-(1-methoxy-1-oxopropan-2-yl)-3,5,6-trimethylbenzenecarboximidic acid

2,4-dihydroxy-n-(1-methoxy-1-oxopropan-2-yl)-3,5,6-trimethylbenzenecarboximidic acid

C14H19NO5 (281.1263)


   

(12s,13s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

(12s,13s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

C17H15NO3 (281.1052)


   

5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-18-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-18-ol

C17H15NO3 (281.1052)


   

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-18-ol

(12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-18-ol

C17H15NO3 (281.1052)


   

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

C18H19NO2 (281.1416)


   

(12r,13r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

(12r,13r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

C17H15NO3 (281.1052)


   

5,11-dihydroxy-9-methoxy-8-methyl-2-(prop-1-en-1-yl)-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

5,11-dihydroxy-9-methoxy-8-methyl-2-(prop-1-en-1-yl)-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,12(20),16,18-hexaen-15-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,12(20),16,18-hexaen-15-ol

C17H15NO3 (281.1052)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

C17H15NO3 (281.1052)


   

(1s,2s,5s,6s,8s,11s)-5,11-dihydroxy-9-methoxy-8-methyl-2-[(1e)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

(1s,2s,5s,6s,8s,11s)-5,11-dihydroxy-9-methoxy-8-methyl-2-[(1e)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

[6-(1-methylindol-7-yl)-2h-1,3-benzodioxol-5-yl]methanol

[6-(1-methylindol-7-yl)-2h-1,3-benzodioxol-5-yl]methanol

C17H15NO3 (281.1052)


   

(9s)-15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-8-one

(9s)-15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-8-one

C17H15NO3 (281.1052)


   

4,4,17-trimethyl-3,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,5,7,9,12(16),13-hexaen-11-one

4,4,17-trimethyl-3,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,5,7,9,12(16),13-hexaen-11-one

C17H15NO3 (281.1052)


   

(9s)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

(9s)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

(2r,4e)-1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2-methylhex-4-en-1-one

(2r,4e)-1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2-methylhex-4-en-1-one

C14H19NO5 (281.1263)


   

(9r)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

(9r)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

(12s,13r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

(12s,13r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-13-ol

C17H15NO3 (281.1052)


   

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

C17H15NO3 (281.1052)


   

2-(4-hydroxyphenyl)-6-methoxy-1-methylquinolin-4-one

2-(4-hydroxyphenyl)-6-methoxy-1-methylquinolin-4-one

C17H15NO3 (281.1052)


   

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C18H19NO2 (281.1416)


   

(1r,5s,16r)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,5s,16r)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C18H19NO2 (281.1416)


   

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-(prop-1-en-1-yl)-2-azaspiro[4.5]dec-7-en-1-one

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-(prop-1-en-1-yl)-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

17-methoxy-5,5-dimethyl-6,13-dioxa-11-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,11,14,16-heptaene

17-methoxy-5,5-dimethyl-6,13-dioxa-11-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,7,9,11,14,16-heptaene

C17H15NO3 (281.1052)


   

3-hydroxy-2,6,8-trimethyl-4a-(2-oxopropyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione

3-hydroxy-2,6,8-trimethyl-4a-(2-oxopropyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione

C11H15N5O4 (281.1124)


   

(9r)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

(9r)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

C17H15NO3 (281.1052)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-17-ol

C17H15NO3 (281.1052)


   

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

(12s)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-7-ol

C17H15NO3 (281.1052)


   

11-methoxy-4,4-dimethyl-3,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,5,7,9,11,13,16-heptaene

11-methoxy-4,4-dimethyl-3,15-dioxa-17-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,5,7,9,11,13,16-heptaene

C17H15NO3 (281.1052)